100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
ATI PHARM MADE EASY 4.0 MUSCULOSKELETAL SYSTEM QUESTIONS AND ANSWERS $14.99   Add to cart

Exam (elaborations)

ATI PHARM MADE EASY 4.0 MUSCULOSKELETAL SYSTEM QUESTIONS AND ANSWERS

 3 views  0 purchase
  • Course
  • ATI Pharm
  • Institution
  • ATI Pharm

ATI PHARM MADE EASY 4.0 MUSCULOSKELETAL SYSTEM QUESTIONS AND ANSWERS

Preview 2 out of 12  pages

  • November 1, 2024
  • 12
  • 2024/2025
  • Exam (elaborations)
  • Unknown
  • ATI Pharm
  • ATI Pharm
avatar-seller
AGRADEPROMASTER
ATI PHARMACOLOGY MADE EASY 4.0 ~
THE NEUROLOGICAL SYSTEM (PART 1)



A6nurse6is6teaching6a6client6who6has6Alzheimer's6disease6and6their6caregiver6about6mem
antine.6Which6of6the6following6instructions6should6the6nurse6include?

A.6Increase6fluid6intake6to6improve6renal6excretion.
B.6Report6memory6loss6or6confusion.
C.6Watch6for6signs6of6liver6impairment,6such6as6jaundice6and6abdominal6pain.
D.6Avoid6taking6over-the-counter6antacids.6-6ans--D.6Avoid6taking6over-the-
counter6antacids.

Rationale:
A.6It6is6not6necessary6to6increase6fluids.6Memantine6is6essentially6unchanged6when6it6is6
excreted6in6the6urine.6Therefore,6it6is6not6necessary6to6increase6fluids6because6fluid6intak
e6does6not6affect6this6process.
B.6Clients6who6have6Alzheimer's6disease6already6have6and6will6continue6to6have6memor
y6loss6and6confusion.6The6drug6can6help6slow6the6progressive6decline,6but6will6not6elimin
ate6the6disease's6manifestations.
C.6Memantine6should6not6result6in6liver6impairment,6although6it6should6be6used6cautiousl
y6with6clients6who6have6severe6liver6impairment.
D.6Antacids6that6contain6sodium6bicarbonate6increase6urine6alkalinity6and6can6decrease6
drug6excretion,6ultimately6leading6to6toxicity.

A6nurse6is6caring6for6a6client6who6has6a6new6prescription6for6pramipexole6to6treat6Parkins
on's6disease.6The6nurse6should6recognize6that6which6of6the6following6laboratory6tests6re
quires6monitoring?

A.6C-reactive6protein
B.6Creatinine6clearance
C.6Thyroid6function
D.6CBC6-6ans--B.6Creatinine6clearance

Rationale:
A.6Pramipexole,6a6direct-acting6dopamine6receptor6agonist,6is6unlikely6to6alter6C-
reactive6protein.6Pravastatin6is6a6drug6that6alters6C-
reactive6protein6in6a6beneficial6way6by6helping6to6lower6the6risk6of6heart6disease.

, B.6Pramipexole,6a6direct-
acting6dopamine6receptor6agonist,6should6be6used6with6caution6for6clients6who6have6ren
al6disease.6Therefore,6the6nurse6should6monitor6the6client's6renal6function.
C.6Pramipexole,6a6direct-
acting6dopamine6receptor6agonist,6is6unlikely6to6alter6thyroid6function.6Amiodarone6is6a6d
rug6that6can6alter6thyroid6function.
D.6Pramipexole,6a6direct-
acting6dopamine6receptor6agonist,6is6unlikely6to6alter6CBCs.6Interferon6beta-
1b,6an6immunomodulator,6can6cause6myelosuppression6and6warrants6monitoring6of6CB
Cs6periodically.

A6nurse6is6caring6for6a6client6who6has6a6new6prescription6for6dantrolene6to6treat6skeletal6
muscle6spasms.6The6nurse6should6instruct6the6client6to6report6which6of6the6following6adv
erse6effects?

A.6Slow6heart6rate
B.6Cough
C.6Diarrhea
D.6Hearing6loss6-6ans--C.6Diarrhea

Rationale:
A.6Dantrolene6is6more6likely6to6cause6tachycardia6than6bradycardia.
B.6Dantrolene6is6unlikely6to6cause6a6cough,6but6it6can6cause6difficulty6swallowing.
C.6Prolonged6diarrhea6can6cause6dehydration6and6other6serious6effects.6Diarrhea,6naus
ea,6and6vomiting6are6adverse6effects6of6dantrolene.6The6client6should6report6these6effect
s6so6the6nurse6can6monitor6fluid6balance6and6intervene6accordingly.
D.6Dantrolene6can6cause6blurred6vision,6but6it6is6unlikely6to6cause6hearing6loss.

A6nurse6is6caring6for6a6client6who6has6a6new6prescription6for6valproic6acid6to6treat6a6seizu
re6disorder.6The6nurse6should6instruct6the6client6to6monitor6for6which6of6the6following6adv
erse6effects?

A.6Hirsutism
B.6Depression
C.6Jaundice
D.6Gum6irritation6-6ans--C.6Jaundice

Rationale:
A.6Valproic6acid6is6unlikely6to6cause6hirsutism,6or6excessive6hair6growth,6but6it6can6cause
6transient6hair6loss.

B.6Valproic6acid6is6unlikely6to6cause6depression,6but6it6can6cause6aggression.
C.6Valproic6acid6can6cause6hepatic6toxicity,6characterized6by6jaundice,6abdominal6pain,6
and6nausea.6Clients6taking6the6drug6should6report6these6manifestations,6and6the6nurse6s
hould6monitor6liver6function6studies6prior6to6treatment6and6periodically6during6therapy.
D.6Valproic6acid6is6unlikely6to6cause6gum6irritation.6Phenytoin6can6cause6gingival6hyperpl
asia.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller AGRADEPROMASTER. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $14.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

71498 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$14.99
  • (0)
  Add to cart